Goldman Sachs has initiated coverage on Cigna Group (CI) with a Buy rating as of October 13, 2025. This marks the firm's first assessment of the company's investment potential, reflecting its analysis of Cigna's business model, industry dynamics, and growth prospects.
Cigna, headquartered in Bloomfield, Connecticut, is a global health company that employs 73,500 full-time staff. The firm operates through two key growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth includes Pharmacy Benefit Services and Specialty and Care Services, which provide coordinated health solutions to enhance the healthcare system. Cigna Healthcare encompasses U.S. Healthcare and International Health segments, delivering comprehensive medical plan services.
As of now, Cigna has a market capitalization of $68.5 billion, a P/E ratio of 11.14, and an EPS of 22.71. The company also boasts a substantial dividend yield of 235.6%. Upcoming earnings are anticipated on July 28, 2026, with an estimated EPS of $8.17 and revenue of $72.4 billion.
Analyst ratings like this one offer insights based on extensive research and financial modeling, but they should be considered alongside a variety of factors, including company fundamentals and industry trends. Ratings can evolve as new information emerges, and differing opinions among analysts are common.
In recent analyst actions, Goldman Sachs' initiation follows other notable ratings, with a consensus of 10 Strong Buy, 18 Buy, and 7 Hold ratings as of November 1, 2025.